İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2020

Triple gastrointestinal prophylactic therapy following high-power short-duration posterior left atrial wall ablation

Indian Heart Journal

YÖKSİS OpenAlex Açık erişim · gold SJR Q3 Atıf 2 Yüzdelik 57.9% FWCI 0.28
Yıl
2020
ISSN
0019-4832
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

The purpose of this study is to investigate incidence of gastrointestinal symptoms and complications in patients who underwent high-power short-duration (HPSD), posterior left atrial wall isolation during atrial fibrillation ablation and thereafter have received gastrointestinal prophylactic regimen consisting of sucralfate, proton-pump inhibitor and colchicine. Patients were followed and assessed at baseline, up until 6th month following the procedures.Among 115 patients who were included, 5 patients (4.3%) reported gastrointestinal symptoms at follow-up. No complications were diagnosed during the follow-up. In conclusion, the HPSD along with prophylactic regimen has been associated with low incidence of gastrointestinal adverse events.

Konular

  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias

Birincil konu Atrial Fibrillation Management and Outcomes

Yazarlar

  1. BAŞAR CANDEMİR ANKARA ÜNİVERSİTESİ
  2. Emir Baskovski ANKARA ÜNİVERSİTESİ
  3. KERİM ESENBOĞA ANKARA ÜNİVERSİTESİ
  4. ALİ TİMUÇİN ALTIN ANKARA ÜNİVERSİTESİ